CANC 380 Final Exam Questions and
Correct Answers/ Latest Update / Already
Graded
Cancer
Ans: A collection of diseases with uncontrolled cell growth.
Disability Adjusted Life Years (DALY)
Ans: A metric combining years lost to premature death and
disability.
Darwinian Evolution
Ans: Theory explaining variation, heritability, and natural
selection.
Innate Immune System
Ans: First line of defense against cancer cells.
Adaptive Immune System
Ans: Tailored response to specific cancer antigens.
All rights reserved © 2025/ 2026 |
, Page |2
Antigen-Presenting Cells
Ans: Cells that display antigens to activate T-cells.
MHC Class I Receptors
Ans: Present intracellular antigens to CD8+ T-cells.
MHC Class II Receptors
Ans: Present extracellular antigens to CD4+ T-cells.
Tumour Antigens
Ans: Substances produced by cancer cells recognized by the
immune system.
War on Cancer
Ans: 1971 initiative aimed at eradicating cancer.
Radiation Therapy
Ans: Treatment using high-energy particles to kill cancer cells.
All rights reserved © 2025/ 2026 |
, Page |3
Chemotherapy
Ans: Use of drugs to kill or slow cancer cell growth.
Hormonal Therapy
Ans: Treatment targeting hormone-sensitive cancers.
Targeted Drugs
Ans: Medications designed to specifically attack cancer cells.
Immunotherapy
Ans: Treatment that boosts the immune response against
cancer.
Evolutionary Biology of Cancer
Ans: Application of evolutionary principles to cancer
development.
Natural Selection in Cancer
Ans: Survival of cancer cells with advantageous mutations.
All rights reserved © 2025/ 2026 |
, Page |4
Research Funding
Ans: Financial resources allocated for cancer research
initiatives.
Economic Impact of Cancer
Ans: Significant costs associated with treatment and loss of
productivity.
Mortality Contribution
Ans: Cancer as a leading cause of death globally.
Media Representation of Cancer
Ans: Critical evaluation of how cancer research is reported.
Historical Progression of Cancer Treatments
Ans: Advancements from early treatments to modern
therapies.
Complexity of Cancer
All rights reserved © 2025/ 2026 |